Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Onco… (NCT07282158) | Clinical Trial Compass
RecruitingNot Applicable
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
United States25 participantsStarted 2026-02-24
Plain-language summary
This clinical trial tests an adapted version of the Helping Ovarian Cancer Patients Cope (HOPE) intervention to address burnout among gynecologic oncology clinicians. Stress and burnout among gynecologic oncology clinicians can have far-reaching impacts not only on physicians at the individual level (e.g., distress, mental illness) but also at the professional (e.g., worse patient outcomes, increased errors) and societal levels (fewer physicians in this specialty, more system strain). The original Helping Ovarian Cancer Patients Cope (HOPE) is a workshop to promote hope among patients with ovarian cancer through creating positive narratives using the hope theory and social-cognitive theory. The adapted intervention for clinicals (HOPE-C) will use the same concepts but tailored to clinician experiences by fostering peer support and retelling their challenging stories and may address burnout for gynecologic oncology clinicians.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18 years of age or older
* English speaking
* Able to provide informed consent
* Working with patients with ovarian cancer (gynecologic oncologists, medical oncologists, nurses, social workers, and advance practice providers \[APPs\])
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial seems to focus on reducing burnout in gynecologic oncology clinicians rather than directly treating patients — can you help me understand how, if at all, participating in or being treated by clinicians in this study would affect my own ovarian cancer care?
2Since this study is in a 'Phase NA' feasibility stage and is primarily measuring whether the HOPE-C intervention can be delivered and accepted by clinicians, what does that mean for what we actually know so far about whether it helps patients like me?
3The trial is listed as actively recruiting right now — do you think being cared for by a clinician who is enrolled in this burnout intervention program could realistically affect the quality or consistency of the emotional support and communication I receive during my treatment?
4Given that this study is about clinician wellbeing rather than a direct treatment for ovarian cancer, should I be looking separately at trials that target my cancer or psychiatric symptoms more directly, and how would you help me prioritize those conversations?
5If my care team includes clinicians participating in this study, how would I know, and is there anything I should ask or watch for in terms of how my psychological support needs are being addressed alongside their own burnout research goals?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Objective 1: Clinician feedback for Helping Ovarian Cancer Patients Cope-Clinician Burnout (HOPE-C)
Timeframe: Day 1
2
Objective 2: Feasibility (Accrual rate)
Timeframe: At time of enrollment
3
Objective 2: Feasibility (Rate of intervention completion)
Timeframe: At 4 weeks
4
Objective 2: Feasibility (Rate of survey completion)
Timeframe: At baseline and 2-week post-intervention